Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing. The ...
Cell therapy is a field rife with innovation, but most of the novel therapies being developed fall into one of two basic categories: autologous cell therapies, which involve removing a patient’s ...
With information overload, rapidly and effectively communicating complex medical data to healthcare professionals, researchers, and patients is crucial. Today’s audiences not only benefit from ...
Pharmaceutical companies are eagerly pursuing GenAI products and use cases to generate value within their organisations. Many are heavily investing in consultants to help develop strategies and ...
Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ...
Swedish pharma company Vicore has won breakthrough status from the FDA for Almee, a cognitive behavioural therapy (CBT) app used to support people with pulmonary fibrosis (PF). Almee takes the ...